Skip to main content
ISTH 2023 Main banner
Back

    State-of-the-Art Session

    Hemophilia and Rare Bleeding Disorders

    Inhibitors and How Do We Deal With Them in 2023

    SOA 25.1 - Hemophilia A: Inhibitor Prevention and Eradication in 2023 and Beyond

    Wednesday, June 28, 2023
    08:30 – 08:55 ET
    Room: 516
    Session Available As: Live-Stream and On-Demand

      Speaker(s)

    • David Lillicrap, MD

      Professor
      Department of Pathology and Molecular Medicine, Queen's University
      Kingston, Ontario, Canada

    Please view the 2023 RPTH State-of-the-Art Illustrated Capsules here.

    Learning Objectives:

    • Understand the impact of FVIII inhibitors on hemophilia management in 2023.
    • Recognize the immunologic challenges posed by the development of FVIII inhibitors.
    • Be aware of possible intervetions to prevent FVIII inhibitors and attain immunologic tolerance to FVIII.